NOVEXUS Tech Version 0: Towards an End-to-End Personalized Pharmaceutical Design Platform — Platform Brief

NOVEXUS Tech — Version 0 Platform Brief

NOVEXUS Tech is a research-driven scientific computing initiative developing original computational technologies and integrating established scientific tools for drug discovery and development. Its long-term vision is to establish an end-to-end personalized pharmaceutical design platform.

The initiative builds on a portfolio of 15 peer-reviewed computational research studies spanning drug discovery and related scientific fields, including consensus blind docking, allosteric binding-site prediction, PROTAC modelling, prodrug prioritisation and molecular property prediction.

Version 0 presents 30 research tools alongside molecular docking and structural bioinformatics interfaces. Of these, 27 research tools have undergone reference-based evaluation using local scientific implementations. These evaluations do not constitute independent end-to-end validation of the deployed docking and structure services.

The development roadmap prioritises scientific benchmarking, integration of NOVEXUS-developed methods, performance-based selection of computational engines and automated multi-stage research workflows. Future objectives include authenticated experiment submission through smartphone applications or text messages, patient-specific modelling and, ultimately, physiology-coupled whole-body simulation of drug exposure and response.

Commercial development initially focuses on expert-reviewed computational decision reports, feasibility studies, research partnerships and specialised services for PROTAC, prodrug and off-target assessment.

This document provides a concise overview of the platform's scientific foundation, current development stage, differentiation, commercial direction and long-term research objectives.

Scope: Strategic and technical overview. Not a peer-reviewed research article, clinical validation study or demonstration of completed personalized whole-body simulation.